Endocrine treatment of prostate cancer-Reference-Cited by-同舟云学术

Endocrine treatment of prostate cancer

Published:2004-11 Issue:4 Volume:92 Page:287-295
ISSN:0960-0760
Container-title:The Journal of Steroid Biochemistry and Molecular Biology
language:en
Short-container-title:The Journal of Steroid Biochemistry and Molecular Biology

Author:

Tammela Teuvo

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference77 articles.

1. Studies on prostate cancer: I. The effect of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate;Huggins;Cancer Res.,1941

2. Hormone therapy for patients with prostate carcinoma;Klotz;Cancer,2000

3. Quantal relationship between prosttaic dihydrotestosterone and prostatic cell content: critical threshold concept;Kyprianou;Prostate,1987

4. PSA decline is an independent prognostic marker in hormonally treated prostate cancer;Palmberg;Eur. Urol.,1999

5. National comprehensive cancer network guidelines for the management of prostate cancer;Scherr;Urology,2003

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suppression of androgen receptor and activation of apoptotic signaling pathway in the prostate cancer LNCaP cells: The synergistic effect of Epigallocatechin-3-gallate and conditioned medium derived from WJ-MSCs;2024-04-17

2. The synergistic effect of EGCG and conditioned medium derived from WJ-MSCs on androgen receptor and apoptotic signaling pathways of prostate cancer LNCaP cells;2023-08-14

3. A comprehensive review on lipid nanocarrier systems for cancer treatment: fabrication, future prospects and clinical trials;Journal of Liposome Research;2023-05-05

4. The synergistic effect of EGCG and conditioned medium derived from WJ-MSCs on androgen receptor and apoptotic signaling pathway in prostate cancer LNCaP cells;2023-03-31

5. Targeting of the Interleukin-13 Receptor (IL-13R)α2 Expressing Prostate Cancer by a Novel Hybrid Lytic Peptide;Biomolecules;2023-02-12